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ABSTRACT  
Aripiprazole belongs to the atypical antipsychotic category of drug, frequently prescribed for the cure of Psychosis. Cytochrome2D6 (CYP2D6) 
is one of the prominent enzymes that play a key role in the metabolism of Aripiprazole and further formation of an active met abolite, 
Dehydroaripiprazole takes place. Patients under the treatment with this potent moiety have been reported with the high blood glucose level as 
a side effect. In addition to this, literature suggests that the leaves of Insulin plant (Costus igneus) are usually administered by diabetic patients 
(2-3 times) to manage the sugar level without concerning to the physicians. There might be probability while concurrent administration of 
(Aripiprazole and Insulin plant leaves), leaves inhibit the enzyme and ultimately Dehydroaripiprazole exhibit poor pharmacological action. 
Hence, the present work was done to investigate the inhibitory effect of Insulin plant extract (IPE) on CYP2D6, with the co -administration of 
Aripiprazole (to examine the changes in a metabolite of Aripiprazole). In order to carry out this protocol firstly, IPE was prepared by the 
successive extraction method. Methanolic extract of Insulin plant was found enriched with the Quercetin, which was used as a marker to carry 
out this study. Presence of Quercetin was confirmed with the Ultra-violet spectroscopy (UV) and High-performance liquid chromatography 
(HPLC) analytical methods. Characterization of Aripiprazole was done with the help of different analytical tools such as: HPLC, melting point, 
and UV. Aripiprazole alone and with the several dilutions of IPE were incubated using isolated rat liver microsome (RLM) and analyzed using 
HPLC. HPLC data demonstrated that the, mixture of IPE+Aripiprazole (herb and drug in liver microsomes), in comparison to Aripiprazole+RLM 
(alone drug in liver microsomes) has not shown any significant inhibition of the enzyme, and inhibitory concentration (IC50) value found to be 
4.49µg/ml. Therefore this study concluded that IPE has shown safe results even at the highest clinical dose after oral administration i.e., 20-
1000µg/ml and did not show any significant CYP2D6 inhibition. Nevertheless, to confirm these observations, inclusion of in vivo studies will be 
advantageous. As per our knowledge, this is the first attempt made on the detection of Herb- Drug interactions (HDI’S) between Insulin plant 
and Aripiprazole. 
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List of abbreviations: 
Abbreviation Expansion 
ACN Acetonitrile 
ADME Absorption, distribution, metabolism, excretion 
BSA Bovine serum albumin 
CI Costus igneus 
CYP2D6 Cytochrome 2D6 
FT-IR Fourier Transform infrared 
HDIs Herb-drug interactions 
HPLC High performance liquid chromatography 
Kcl Potassium chloride 
LC-MS Liquid chromatography- Mass Spectrometry 
MeoH Methanol 
MS Mass Spectrometry 
Abbreviation Expansion 
NADPH Nicotinamide adenine Dihydrogen phosphate 
PDA Photo Diode Array 
Rf Retention factor 
RH Relative Humidity 
RLM Rat liver microsome 
RPM Revolutions per minute 
Rt Retention time 
TLC Thin layer chromatography 
USFDA United State Food and Drug Administration 
UV Ultra-violet 
WHO World Health Organization 
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Fig.1. Insulin plant Fig.2. Leaves after Drying 
1. INTRODUCTION:  
In the era of safe and efficacious drug delivery, modern and 
herbal drugs are administered simultaneously to achieve the 
good therapeutic outcomes. In consequences of this, concept 
of Herb-drug interactions (HDI’S) study is very demanding 
and fascinating. These interactions might alter the 
Pharmacokinetics (ADME; Absorption, distribution, 
metabolism excretion) or Pharmacodynamics of the 
simultaneously administered moieties, and results in 
inhibition or stimulation of metabolism enzymes 1. On the 
basis of survey by World Health Organization (WHO) it is 
found that globally, 90% of the population is using herbal to 
maintain the natural health. As we are aware, people have 
mindset that herbal therapies are  safe in the terms of 
toxicity and are consumed as home remedies 2, 3. In such 
cases, a patient is already under Allopathy therapy, should 
avoid taking Ayurvedic medicaments concurrently or must 
take after consultation with the doctor. Negligence of 
together administration can be either more toxic, synergistic 
or antagonistic impact. But still, there are number of cases 
where patients do not consult with the physician and suffers 
from dangerous phenomenon. Many clinically proven 
likewise; St John’s, Ginkgo biloba and Panax ginseng are well-
noted examples in the class of HDI’S 4, 5. Many regulatory 
bodies viz. United State Food and Drug Administration 
(USFDA) took serious act and recommended to follow the 
guidelines to avoid HDI 6. However, deep knowledge of 
pharmacokinetic profile of both Herb and drug will also 
enlighten the basic idea to understand the type of 
interaction, if any 7. In the same manner, to observe HDI 
(inhibitory effect) using Aripiprazole as drug and Insulin 
plant as a herb, we have designed this protocol. 
Aripiprazole is a second-generation USFDA approved drug 
candidate which is used to treat the bipolar disorder 8. Upon 
its Oral ingestion, metabolism of the Abilify governs by the 
CYP2D6, which formed an active metabolite i.e. 
Dehydroaripiprazole. Some drugs such as Fluoxetine, 
Paroxetine have been found with the inhibiting potential for 
the CYP2D6 9, 10. After seeing these huge data (potent 
inhibitory effects) we have decided to study only inhibitory 
interaction. Report says, treatment with Abilify causes 
glucose impairment (diabetic situation) 11. 
Insulin plant also called as Costus igneus, family Costaceae is 
an extensively known for its therapeutic potential. Leaf part 
of this plant has possessed abundant antidiabetic potential. 
According to the Ayurveda, daily consumption of one leaf can 
bring the glucose level normal 12, 13. To balance the glucose 
level, patients are advised to take anti-diabetic drugs (herbal 
extract or marketed drug). There might be cases, patients 
will be administering both i.e. Aripiprazole (prescribed drug) 
and Insulin plant leaves or extracts without informing 
practitioners. For primary level understanding of HDIs 
present study was designed and inhibitory effect of IPE on 
CYP2D6 examined. 
2. MATERIALS AND METHODS: 
2.1 Chemicals, reagents and solvents: Aripiprazole was 
received as a gift sample from FTF Pharma, India. 
Quercetin was procured from Sigma laboratory. 
Chloroform, Dichloromethane, Absolute Ethanol, 
Formaldehyde, Methanol, Isopropyl alcohol, Ethyl 
acetate, Petroleum ether, Acetonitrile was used during 
the study. All solvents (analytical grade) were 
purchased from the E-Merck and Fisher Scientific 
laboratories. The major instruments used for the study 
are described as follows: Analytical balance (Mettler 
Toledo JB1603), Rotavapour (Buchi Rotavapor R-210), 
Filtration Pump (Millipore vaccum), Stirrer (REMI 
3MLH and Eltech digimag), Melting point apparatus 
(Veego VMP-DS), Infrared (IR) spectrophotometer 
[ShimadzuERS-8000 Fourier Transform (FT-IR)], 
Homogeniser (Polytron, PT2500E), HPLC (LC-2010 HT, 
Shimadzu), Refrigerated Centrifuge model Universal 
320 R (Hettich), Refrigerated ultracentrifuge (OPTIMA 
max-XP ultracentrifuge), UV/Visible Spectro-
photometer (Shimadzu-1800, Japan), Water bath 
(Yorco), Dry bath (Yorco), Shaker (Orbitek, Scigenics). 
2.2 Collection of the plant material: Insulin plant was 
received as a gift sample from one nursery of Pune, 
Maharashtra (Fig. 1). Authentication of the plant was 
done by Dr. Hitesh Solnaki, Professor, Gujarat 
University, and Ahmedabad, India. 
2.3 Preparation of Insulin plant extract: After 
authentication, leaves were collected, dried at room 
temperature for 2-3 days (Fig. 2) and powdered. 
Weighed out the powder material and kept it with 
solvent (Methanol) for 24 hours then filtered and 
concentrated each filtrate fraction by rotavapor 14. 
Extract of methanol indicated the presence of Quercetin 
which was compared with the standard Quercetin by 
TLC. Percentage yield of extract was calculated. An 
extract was dried and kept in aluminium coated 
polyethylene bags. 
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2.4 Chemical Characterization: 
2.4.1 Chemical characterization of prepared extract: 
2.4.1.1 Preliminary phytochemical screening: Extract of 
Insulin plant was subjected to phytochemical tests to 
determine the presence of active secondary metabolite 
using standard procedures 15. 
2.4.1.2 HPLC studies for standardization of plant extract: 
Methanolic extract was characterized qualitatively and 
quantitatively through HPLC for this, ACN: MQ (3pH) 
was used as mobile phase. Accurately weighed 25 mg 
of standard Quercetin was transferred to a 25 ml 
volumetric flask and dissolved in Methanol. Volume 
make up was done with methanol to obtain standard 
stock solution of concentration 1000µg/ml, and diluted 
for next required samples. Same procedure was 
followed for extract. 
2.4.1.3 UV spectroscopy of Methanolic extract: 10mg of 
Quercetin was dissolved in 100 ml of methanol. From 
this, different dilutions were prepared in the 
concentration of 2, 4, 6, 8, 10, and 12µg/ml. 
2.4.2 Characterization of Aripiprazole: Characterization of 
Aripiprazole was done using HPLC, UV 
spectrophotometry, IR and melting points. 
2.4.2.1 HPLC: HPLC was done to determine the purity of the 
selected drug. Aripiprazole was dissolved in the 
respective solvents of analytical grade and HPLC 
analysis was performed (Table 1). 
Table1: HPLC conditions for Aripiprazole 
Drug Aripiprazole 
Mobile phase Acetonitrile : Ammonium acetate 
(90:10 V/V) 
Reported λ max 214 nm 
Detector Photodiode array (PDA) detector 
Injection volume 5µl 
Column C18 Kromasil 
 
2.4.2.2 Absorbance maxima determination: An Absorbance 
maximum of Aripiprazole was determined after 
dissolving in methanol. 
2.4.2.3 Melting point and FTIR spectroscopy 
determination: Melting point determination of 
Aripiprazole was performed using Melting point 
apparatus. For IR study, Aripiprazole pellet was 
prepared and finger printing was taken out. 
2.5 Isolation of rat liver microsome: Swiss Wistar strain 
rats (120-15 g) were used in this procedure. The study 
was approved by the Animal ethical committee 
affiliated to the National Institute of Pharmaceutical 
Education and Research Institutional Animal Ethical 
Committee (NIPER-A/IAEC/2017/031/R). Rat was 
anesthetised using Xylazine, sacrificed and liver was 
isolated and perfused with the 1.15% KCl. In the next 
step, homogenization was done with the help of 
homogenizer, and sample was allowed for centrifuged 
at 9600 rpm for 20 minute at 4:C. Further, ultra-
centrifuged was carried out at 1, 05,000 rpm for 30 
minute at 4:C. Pellets formed were transferred in 
sample tube and stored at -80:C in fridge until use [16]. 
2.6 Development of calibration curve using Bovine 
Serum Albumin (BSA) and protein estimation using 
Bradford method: 96 well plates were employed for 
this study. For calibration curve; 210µl reaction 
mixture containing 200µl of Bradford reagent, 8µl of 
water and 2 µl of BSA was taken. 10 µl of water and 
200µl of Bradford reagent used as control. Water and 
BSA concentration were varying from 2µl-10µl and 
absorbance took at 595 nm. Each concentration was 
reported in triplicate [17]. 
2.7 Measurement of effects of extract in the 
combination with Aripiprazole on CYP2D6 using 
HPLC: Determination of Aripiprazole and 
Dehydroaripiprazole was done using reported HPLC 
method [18]. Briefly, chromatographic separations 
were carried out on RP C- 18 kromasil column (250mm 
× 4.6 mm, 5 μm particle size) using Acetonitrile and 
Ammonium acetate (90:10, v/v) as a mobile phase for 
15 min with the flow rate of 1ml/min using photodiode 
array detector (PDA). Aripiprazole was used as a probe 
substrate and formation of Dehydroaripiprazole was 
used as a measure of CYP2D6 activity. Briefly, in 
sample tubes 250 μL reaction mixture containing 10 μL 
phosphate buffer (pH 7.4), 10 μL of test samples 
(extract 20-1000μg/ml), 10 μL of Aripiprazole 
(5μg/mL) and 205 μL of RLM were added. The reaction 
was initiated with the addition of 25μL of Nicotinamide 
adenine Dihydrogen phosphate (NADPH-2mMol/L). 
Followed by, it was incubated in a shaking water bath 
at 37 ℃ for 15  min. The reaction was stopped by the 
addition of ice-cold 100 μL of methanol and mixture 
was extracted with the 1 mL of ice-cold ethyl acetate, 
which was then vigorously vortexed for 2 min and 
centrifuged at 13,000 rpm for 5 minutes. An organic 
phase was transferred into a clean tube and 
evaporated to dryness under a nitrogen stream. The 
residue was reconstituted in 100 μL mobile phase and 
used for the HPLC analysis and assay was performed in 
triplicate. 
2.8 Calculation of Inhibitory concentration (IC50) 
Value:  
% control activity = (Peak area of Dehydroaripiprazole 
in the presence of extract/peak area of 
Dehydroaripiprazole in control) ×100 and % 
inhibitory activity = 100-%control activity was 
calculated using these formula. IC50 value was 
calculated from the Graph Pad Prism5. The graph was 
obtained between log concentration and % of 
inhibitory. 
3. RESULTS: 
3.1 Determination of Percentage yield: The percentage 
yield of IPE was found to be 10.845% (W/W). 
3.2 Chemical characterization of prepared extract: 
3.2.1 Preliminary phytochemicals screening: TLC for 
extract has been performed with respect to the suitable 
mobile phase. Methanolic extract was found to be 
enriched with Quercetin as analytical marker (Fig.3 & 
Fig.4). Further, quantification was carried out in next 
step.
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Fig.3. TLC of Methanolic leaves extract Fig. 4. TLC of Methanolic extract with standard Quercetin 
 
 
Fig.5. Chemical structure of Quercetin 
3.2.2 HPLC studies for standardization of plant extract: HPLC revealed the presence of Quercetin in the IPE (Table 2 & 3). 
Table 2 HPLC conditions for extract standardization 
Extract Methanolic 
 
Mobile phase 
Acetonitrile : MQ with 3 pH (HPLC grade) 
(60:40 V/V) 
Reported λ max 253 nm 
Detector Photodiode array (PDA) detector 
Injection volume 5 µl 
Column Kinetica C18 
Run time 10 minute 
 
Table 3 HPLC observations for standard and extract Quercetin 
Sr. No. Name Rt Wavelength Area Peak purity 
1 Quercetin 12.6 253 nm 1719606 0.980497 
2. Methanolic extract of Insulin plant 13.42 253 nm 392489 1 
 
     
Fig.6. HPLC chromatogram of standard Quercetin                  Fig.7. HPLC chromatogram of Quercetin for extract 
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3.2.3 UV spectroscopy for Methanolic extract: In extract, Quercetin was found to be in 3.9604µg/ml (Fig. 8) and following 
table summarizes about dilutions (Table 4). 
Table 4 Quantitative estimation of Quercetin using UV 
Concentration(µg/ml) Absorbance 
2 0. 117 
4 0. 262 
6 0.412 
8 0.535 
10 0.670 
12 0.804 
 
 
Fig.8. Calibration curve plotted using standard Quercetin 
 
3.3 Characterization of Aripiprazole: 
 
Fig.9. Chemical structure of Aripiprazole 
 
3.3.1 HPLC of Aripiprazole: Following chromatogram was observed (Fig. 10) 
 
Fig.10. Chromatogram of Aripiprazole 
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3.3.2 Absorbance maxima determination: To check the purity of Aripiprazole, absorbance maxima was done. Absorbance 
was measured in spectrum mode (Fig. 11). 
 
Fig.11. UV Spectrum of Aripiprazole 
3.3.3 Melting point and IR spectra determination: Following (Table 5) described melting point observation. And finger print 
is shown on (Fig.12). 
Table 5 Melting point of substrate Aripiprazole 
Substrate Reported melting point Observed melting point 
Aripiprazole 139.0-139.5ºC 139. 0ºC 
 
          
Fig.12. IR spectra for Aripiprazole 
3.3.4 Protein estimation by Bradford method: Protein estimation was done and following table (Table 6) and graph was 
observed (Fig.13). 
Table 6 Protein estimation absorbance 
Concentration(µg/ml) Absorbance 
2 0.158 
4 0.307 
6 0.447 
8 0.508 
10 0.62 
 
 
Fig. 13. Calibration curve plotted of standard BSA 
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3.3.5 Measurement of the inhibitory effects of IPE in combination with Aripiprazole on CYP2D6 using HPLC: Following 
graphs show the presence of Aripiprazole peak and there was no peaks changes (shift, presence, absence) were noted, 
when Aripiprazole was treated with the IPE and RLM. 
 
Fig.14. Chromatogram of Aripiprazole using HPLC 
 
Fig.15. Mixture of only Aripiprazole + rat liver microsome 
 
Fig.16. Mixture of Aripiprazole + RLM + IPE-200µg/ml 
 
Fig.17. Aripiprazole + RLM + IPE-400µg/m 
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Fig.18. Mixture of Aripiprazole + RLM + IPE-600µg/ml 
 
Fig.19. Mixture of Aripiprazole + RLM + IPE-800µg/ml 
 
Fig.20. Mixture of Aripiprazole + RLM + IPE-1000µg/ml  
Table 7 Effect of different concentration of IPE on CYP2D6 
Log concentration (µg/ml) Inhibition 
4.301 0.107 0±0.0065 
4.602 0.221 0±0.0076 
4.778 0.268 8±0.0096 
4.903 0.551 5±0.075 
5 0.221 1± 0.0083 
Data are represented as mean ± standard (n=3) 
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4. DISCUSSION:  
IPE was prepared by the successive extraction method. 
Further, Preliminary phytochemical screening was 
performed and Methanolic extract was found to be enriched 
with the analytical marker Quercetin. TLC was performed 
with the standard Quercetin and retention factor (Rf) value 
was found to be 0.6. Qualitative and quantitative 
determination was done using HPLC and UV which was 
found to be 3.96µg/ml. Additionally, characterization of 
Aripiprazole was carried out. In the next step, RLM were 
isolated and kept at -80ºC and protein concentration was 
found to be 2.92µg/ml using BSA as standard. HPLC study 
showed that no significant changes were observed in the 
retention time (Rt) of Aripiprazole when incubated along 
with the IPE and RLM, and IC50 value was found to be 
4.49µg/ml (Table 8). 
5. CONCLUSION:  
This research narrows down the path of scientists working 
in the same field. Our work suggests that IPE did not show 
any significant CYP2D6 inhibition even at the concentration 
equivalent to the highest clinical dose after oral 
administration i.e., 20- 1000µg/ml. The IC50 value of extract 
of Insulin plant has been found to be below 1000μg/mL. 
Since Ayurvedic physicians typically use much lower doses 
of these extracts than the doses used here hence, the chances 
of interactions (inhibitory) are very rare. 
Future perspective: This study (primary level 
observations) opens a door for the scientist working in the 
same area to look ahead. Evidence of In vitro followed by in 
vivo, will be much helpful to avoid any clinical challenges. 
Study of pharmacokinetic parameters for IPE will be good 
approach to track and reveal the HDIs. 
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